Genmab |
Date/Time | / |
Chg. / Chg.(%) | - / |
Bid | - |
Ask | - |
Open | - |
Previous Close | - |
High | - |
Low | - |
Volume [NOK] | - |
Volume [Units] | |
Price fixings | |
ISIN | DK0010272202 |
Security | GENC |
Exchange | Oslo |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Cboe Europe .. | 2,205.00 | ![]() |
26,722 |
London Inter.. | 2,205.6 | ![]() |
18,148 |
Turquoise | 2,207.50 | ![]() |
8,718 |
Cboe Europe .. | 2,204.50 | ![]() |
437 |
Nasdaq Other.. | 359.6700 | ![]() |
150 |
TradeGate | 296.200 | ![]() |
87 |
gettex | 298.100 | ![]() |
26 |
Frankfurt | 296.4000 | ![]() |
21 |
Cboe Europe .. | 2,203.00 | ![]() |
6 |
Vienna Globa.. | 296.40 | ![]() |
0 |
München | 291.00 | ![]() |
0 |
Düsseldorf | 294.20 | ![]() |
0 |
Berlin | 295.10 | ![]() |
0 |
Lang & Schwa.. | 294.70 | ![]() |
|
Stuttgart | 296.600 | ![]() |
|
OMX Nordic | 2,181.00 | ![]() |
130,621 |
Mexico | 7,638.15 | ![]() |
11,330 |
News
- Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
10:00 - GlobeNewswire - Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
04/09/2021 / 22:00 - GlobeNewswire - Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
04/01/2021 / 12:45 - GlobeNewswire - Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
03/31/2021 / 12:45 - GlobeNewswire - BioNTech Announces Full Year 2020 Financial Results and Corporate Update
03/30/2021 / 12:30 - GlobeNewswire